This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Yadira Lobaina Mato: Innovator in Hepatitis B Research
Introduction
Yadira Lobaina Mato is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions for the treatment of hepatitis B. With two patents to her name, her work is paving the way for advancements in immunotherapy and drug development.
Latest Patents
Yadira's latest patents focus on a pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus (HBV). This innovative composition contains the surface antigen (HBsAg) and the nucleocapsid antigen (HBcAg), with the latter comprising over 45% messenger ribonucleic acid (mRNA). The unique formulation is designed for the prevention and treatment of chronic hepatitis B. Furthermore, it has applications in the production of drugs for immuno-prophylaxis and immunotherapy against HBV infection, enhancing the immune response when co-administered with additional antigens.
Career Highlights
Yadira Lobaina Mato is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she conducts her research and development activities. Her work has garnered attention for its potential impact on public health, particularly in regions where hepatitis B is prevalent.
Collaborations
Throughout her career, Yadira has
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile